AI assistant
ContourGlobal PLC — Director's Dealing 2018
Jun 20, 2018
9182_dirs_2018-06-20_bd94b8d5-bf17-4604-add5-52ce6f8b6840.html
Director's Dealing
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 0345S
ContourGlobal PLC
20 June 2018
20 June 2018
ContourGlobal plc
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility
Pursuant to the notification obligations in accordance with Article 19 of the Market Abuse Regulation, the Company has been notified of the following acquisitions of ordinary shares by Daniel Camus (Non-Executive Director).
1.
Details of PDMR
a)
Name
Daniel Camus
2.
Details of PDMR
a)
Position / status
Non-Executive Director
b)
Initial notification / amendment
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
ContourGlobal PLC
b)
LEI
5493002I3A4J5TFOR115
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
c)
Description of the financial instrument
Ordinary shares of £0.01 each
ISIN: GB00BF448H58
d)
Nature of the transaction
Acquisition
e)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| £2.1467 | 17,500 |
| £2.1461 | 17,500 |
f)
Aggregated information
Aggregated volume
Price
35,000
£2.1464
g)
Date of the transaction
2018-06-19
h)
Place of the transaction
LONDON STOCK EXCHANGE XLON
Enquiries:
Investor Relations - ContourGlobal plc
Gregory Johnson
Tel: +44 207 355 7321
Media - Brunswick
Charles Pretzlik/Simon Maine
Tel: +44 (0) 207 404 5959
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHSEDFDSFASEDM